Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 95 results found. Search for [ NPPA ]

Results 60 to 80 of 95
PTI
New Delhi, April 8, 2015
The government has allowed pharmaceutical companies to hike rates of 509 essential medicines used for treating various ailments like diabetes, hepatitis and cancer by 3.84 per cent with effect from April 1.


PTI
New Delhi, March 19, 2015
The government has exempted drugs and pharmaceuticals from the the levy of Education Cess and Secondary and Higher Education Cess, resulting into reduction of excise duty from 6.18 per cent to 6 per cent.


PTI
New Delhi, March 3, 2015
Out of 509 drugs, above 40 per cent price reduction has happened in the case of 127 essential medicines, while prices of 34 drugs has come down in the range of 35-40 per cent,


PB Jayakumar
January 22, 2015
In the past few years, about six drugs were denied patents in India, as the Indian patent system does not allow incremental innovations.


Ajay Tyagi & Munish Shekhavat
New Delhi, December 26, 2014
The government sought to put controls on drugmakers when it came to pricing of essential drugs, including those for common cough and cold as also for cancer and other diseases.


Zeba Siddiqui
Mumbai, December 17, 2014
The Swiss drugmaker did not provide any details on the lawsuit, but termed Cipla's request for revocation of the patents as \"unfounded\".


Zeba Siddiqui
Mumbai, December 12, 2014
Besides commonly-used antibiotics and pain-killers, the new drugs to come under price control include medicines used for treating cancer and skin disorders.


PTI
New Delhi, December 2, 2014
The government in considering the free essential drugs scheme in a bid to bring down out-of-pocket expenditure of an individual on health care.


PTI
New Delhi, December 2, 2014
Among others, the price monitoring cells will render technical assistance to State Drug Controllers and NPPA in monitoring the notified price of medicines.


Sanjeev Jha
November 17, 2014
From a business model innovation perspective, I believe the companies need to leverage both their wealth of experience and market realities.


PTI
New Delhi, November 7, 2014
Net sales rose to Rs 227.83 crore for the second quarter, as against Rs 209.18 crore for the same period of previous fiscal, Novartis India said in a BSE filing.


PTI
Mumbai, October 13, 2014
The Swiss drugmaker, which did not confirm the quantum of the total penalty by the the National Pharmaceutical Pricing Authority (NPPA), said the notice is \"erroneous and entirely misconceived\".


Sumeet Chatterjee
Mumbai, October 7, 2014
The drugmaker will own 75 per cent stake in the plant being set up in partnership with its local distributor, will invest about Rs 2.25 billion over 3 years.


E Kumar Sharma
September 24, 2014
\"This is for the first time, I think, that a pharma policy has been rolled back... It is a very positive move,\" Biocon Chairperson and MD Kiran Mazumdar-Shaw said.


Zeba Siddiqui
Mumbai, September 23, 2014
The government has withdrawn guidelines issued on May 29 that gave the drug pricing regulator power to fix prices of drugs deemed non-essential.


Mail Today Bureau
New Delhi, September 20, 2014
Major drug companies, including Cipla, Ranbaxy, Lupin and Cadila, are likely to be impacted by the decision.


Aditya Kalra and Zeba Siddiqui
New Delhi/Mumbai, September 19, 2014
Drugmakers, including Cipla, Ranbaxy Laboratories, and Cadila Healthcare are among the companies that will be affected by the latest decision.


PTI
Hyderabad, August 11, 2014
According to Teva, it has received a Para-IV notice from the Indian drug maker over Copaxone, and the lawsuit may trigger a 30-month stay of FDA approval of Dr Reddy's Abbreviated New Drug Application.


PTI
New Delhi, July 30, 2014
Consolidated net sales of the company also rose to Rs 3,284 crore for the quarter under consideration as against Rs 2,420.7 crore for the same period a year ago.


Neetu Chandra Sharma
New Delhi, July 24, 2014
The pricing anomaly has been caught by National Pharmaceutical Pricing Authority which has filed 22 cases this year alone, sending out demand notices that add up to Rs 221.78 crore.


PAGES 4 OF 5  12345